IT1273751B - Derivati azaciclici - Google Patents

Derivati azaciclici

Info

Publication number
IT1273751B
IT1273751B ITMI940238A ITMI940238A IT1273751B IT 1273751 B IT1273751 B IT 1273751B IT MI940238 A ITMI940238 A IT MI940238A IT MI940238 A ITMI940238 A IT MI940238A IT 1273751 B IT1273751 B IT 1273751B
Authority
IT
Italy
Prior art keywords
azacyclic derivatives
azacyclic
derivatives
formula
hyponatraemic
Prior art date
Application number
ITMI940238A
Other languages
English (en)
Inventor
Giuseppe Giardina
Mario Grugni
Roberto Colle
Original Assignee
Smithkline Beecham Farma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Farma filed Critical Smithkline Beecham Farma
Priority to ITMI940238A priority Critical patent/IT1273751B/it
Publication of ITMI940238A0 publication Critical patent/ITMI940238A0/it
Priority to PCT/EP1995/000345 priority patent/WO1995021843A1/en
Priority to JP07520934A priority patent/JP3135577B2/ja
Priority to EP95908236A priority patent/EP0743944A1/en
Publication of ITMI940238A1 publication Critical patent/ITMI940238A1/it
Application granted granted Critical
Publication of IT1273751B publication Critical patent/IT1273751B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Derivati azaciclici di formula generale (I) (FORMULA I) in cui:ciascuno di X e Y è indipendentemente CH o N;RCO è un gruppo acilico;utili nel trattamento di condizioni patologiche iponatriemiche, ischemia cerebrale e dolore.
ITMI940238A 1994-02-11 1994-02-11 Derivati azaciclici IT1273751B (it)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ITMI940238A IT1273751B (it) 1994-02-11 1994-02-11 Derivati azaciclici
PCT/EP1995/000345 WO1995021843A1 (en) 1994-02-11 1995-01-31 Azacyclic derivatives
JP07520934A JP3135577B2 (ja) 1994-02-11 1995-01-31 アザ環式誘導体
EP95908236A EP0743944A1 (en) 1994-02-11 1995-01-31 Azacyclic derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI940238A IT1273751B (it) 1994-02-11 1994-02-11 Derivati azaciclici

Publications (3)

Publication Number Publication Date
ITMI940238A0 ITMI940238A0 (it) 1994-02-11
ITMI940238A1 ITMI940238A1 (it) 1995-08-11
IT1273751B true IT1273751B (it) 1997-07-10

Family

ID=11367820

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI940238A IT1273751B (it) 1994-02-11 1994-02-11 Derivati azaciclici

Country Status (4)

Country Link
EP (1) EP0743944A1 (it)
JP (1) JP3135577B2 (it)
IT (1) IT1273751B (it)
WO (1) WO1995021843A1 (it)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642268B2 (en) 1994-09-13 2003-11-04 G.D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
US6262277B1 (en) 1994-09-13 2001-07-17 G.D. Searle And Company Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
US6268392B1 (en) 1994-09-13 2001-07-31 G. D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
NZ331001A (en) 1996-11-25 2000-05-26 Toray Industries Use of an opiate K receptor agonist as an antipruritic
IL143949A0 (en) 1998-12-23 2002-04-21 Searle Llc Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
DK1140185T3 (da) 1998-12-23 2003-09-29 Searle Llc Kombinationer af cholesterylestertransferhæmmere og galdesyre kompleksdannende forbindelser til hjertekar indikationer
WO2000038726A1 (en) 1998-12-23 2000-07-06 G.D. Searle Llc Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications
ATE240120T1 (de) 1998-12-23 2003-05-15 Searle Llc Kombinationen von ileumgallensäuretransports inhibitoren und fibronsäure derivaten für kardiovaskuläre indikationen
WO2000038721A1 (en) 1998-12-23 2000-07-06 G.D. Searle Llc Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications
EP1140190B1 (en) 1998-12-23 2002-11-20 G.D. Searle LLC. Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indications
AU2157400A (en) 1998-12-23 2000-07-31 G.D. Searle & Co. Combinations of cholesteryl ester transfer protein inhibitors and hmg coa reductase inhibitors for cardiovascular indications
JP3080088B2 (ja) 1999-02-01 2000-08-21 ミノルタ株式会社 電子写真感光体
JP2001034003A (ja) 1999-07-19 2001-02-09 Minolta Co Ltd 電子写真感光体
HK1052183A1 (zh) 2000-03-10 2003-09-05 Pharmacia Corporation 制造tetrahydrobenzothiepines的方法
JP2005518347A (ja) 2001-11-02 2005-06-23 ジー．ディー． サール エルエルシー 頂端ナトリウム共依存性胆汁酸輸送（ａｓｂｔ）およびタウロコール酸塩取り込みの阻害剤としての新規一および二フッ化ベンゾチエピン化合物
BR0306643A (pt) 2002-01-17 2004-10-19 Pharmacia Corp Novos compostos de hidroxi alquil/aril ou ceto tiepina como inibidores do transporte co-dependente de ácido biliar-sódio apical
US7709468B2 (en) 2005-09-02 2010-05-04 Abbott Laboratories Imidazo based heterocycles

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR890012970A (ko) * 1988-02-23 1989-09-20 추후보충 테트라히드로 이소퀴놀린 유도체
FI892468A7 (fi) * 1988-05-23 1989-11-24 Glaxo Group Ltd Piperazinderivat.
US5021413B1 (en) * 1988-08-24 1994-12-13 Sankyo Co Analgesic thiomorpholins, their preparation, and pharmaceutical compositions containing them
GB8824400D0 (en) * 1988-10-18 1988-11-23 Glaxo Group Ltd Chemical compounds
EP0398720A3 (en) * 1989-05-18 1991-07-03 Glaxo Group Limited Piperazine derivatives

Also Published As

Publication number Publication date
EP0743944A1 (en) 1996-11-27
JP3135577B2 (ja) 2001-02-19
JPH09508635A (ja) 1997-09-02
ITMI940238A0 (it) 1994-02-11
WO1995021843A1 (en) 1995-08-17
ITMI940238A1 (it) 1995-08-11

Similar Documents

Publication Publication Date Title
IT1273751B (it) Derivati azaciclici
ATE199906T1 (de) Phosphonat-nukleotid ester-derivate
DE69811867D1 (de) Kleine moleküle anwendbar in der behandlung von entzündgskrankheiten
DK1143967T3 (da) Anticonvulsive derivater egnede til behandling af Hortons hovedpine
BR9306250A (pt) Conjuntos de prato e copo
PT892780E (pt) Analogos de m-amidino fenilo como inibidores do factor xa
RU94042393A (ru) Галихондрины, родственные соединения и способ лечения опухоли у млекопитающих
IT1285770B1 (it) Composti corticoidei
MX9302931A (es) Nuevas 4-aza-5&-colestan-onas 7b-substituidas como inhibidores de 5&-reductasa.
MX9400434A (es) Potenciamiento de temozolomida en celulas de tumores humanos.
TR199900505T2 (it)
ES2118945T3 (es) Derivados de melamina utilizados en el tratamiento del cancer.
IT1264965B1 (it) Uso di alfa 1-bloccanti nel trattamento della eiaculazione precoce
MX9302951A (es) Composicion farmaceutica para tratar la hiperproliferacion celular.
GB9621814D0 (en) Metalloproteinase inhibitors
ES2186807T3 (es) Inhibidores de trombina.
NO20001758L (no) FremgangsmÕter og blandinger for behandling av leddgikt
DK1143917T3 (da) Antikonvulsive derivater egnet til behandling af posttraumatisk stresssygdom
ES2136628T3 (es) 4-iminoquinolinas, procedimiento para su preparacion y su empleo.
ITFI910067A0 (it) Attrezzatura per diamantare i bordi di catene ornamentali
FI890587L (fi) Reaktorkammare i en reaktor med fluidiserad baedd.
IT1204414B (it) Analoghi di amminoprostaglandine 5,6-epossi-7-ossabicicloeptano sostituite,utili nel trattamento di trombosi
MX9603087A (es) Procedimiento para la obtencion de aminocarboniltriazolinonas substituidas.
ES2013293B3 (es) Metodo para el aclarado y estabilizacion de un medio de cultivo de celulas.
BR9407232A (pt) Compostos de tiocarbamoíla

Legal Events

Date Code Title Description
0001 Granted